1 Selmaj K et al. (1991) Colocalization of TCRγδ lymphocytes and hsp-65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci USA88: 6452–6456.
2.
2 Raine CS. (1994) The Dale E. McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion. Ann Neurol36: 561–572.
3.
3 Cannella B, Raine CS. (1995) The adhesion molecule/cytokine prof ile of multiple sclerosis lesions. Ann Neurol37: 424–435.
4.
4 Prineas JW, Connell F. (1979) Remyelination in multiple sclerosis. Ann Neurol5: 22–31.
5.
5 Raine CS, Wu E. (1993) Multiple sclerosis: Remyelination in acute lesions. J Neuropath Exp Neurol52: 199–205.
6.
6 Prineas JW et al. (1993) Multiple sclerosis: Remyelination of nascent lesions. Ann Neurol33: 137–151.
7.
7 Raine CS et al. (1981) Multiple sclerosis: Oligodendrocyte survival and proliferation in an active, established lesion. Lab Invest45: 534–546.
8.
8 Prineas JW et al. (1989) Multiple sclerosis: Oligodendrocyte proliferation and differentiation in fresh lesions. Lab In vest61: 489–503.
9.
9 Raine CS et al. (1994) The immunologic response of the oligodendrocyte in the active multiple sclerosis lesion.A Multidisciplinary Approach to Myelin Diseases.S. Salvati (ed); Plenum, New York, pp. 143–151.
10.
10 Wu E, Raine CS. (1992) Multiple sclerosis: Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, non-demyelinating conditions. Lab Invest67: 88–99.
11.
11 Wu E et al. (1993) SP-40, 40 immunoreactivity in inflammatory CNS lesions displaying astrocyte/oligodendrocyte interactions. J Neuropath Exp Neurol52: 129–134.
12.
12 Jäättelä M, Wissing D. (1993) Heat shock proteins protect cells from monocyte cytotoxicity: Possible mechanisms of self-protection. J Exp Med177: 231–236.
13.
13 Hisaeda H et al. (1995) γδ T cells play an important role in hsp 65 expression and in acquiring protective immune responses against infection withToxoplasma gondii. J Immunol154: 244–251.
14.
14 Capello E et al. (1996) Differential expression of a novel candidate autoantigen, x2 MBP, in multiple sclerosis (MS) lesions. J Neuropath Exp Neurol55: 640 (Abstract).
15.
15 Bonetti B, Raine CS. (1996) BCL-2 and Fas system molecule expression in multiple sclerosis lesions. J Neuropath Exp Neurol55: 641 (Abstract).
16.
16 Raine CS. (1990) Demyelinating diseases.Texbook of Neuropathology(Second Edition), Davis RL and Robertson DM. (eds); Williams and Wilkins, Baltimore; pp. 535–620.
17.
17 Katz D et al. (1993) Correlation between MRI findings and lesion development in chronic active multiple sclerosis. Ann Neurol34: 661–669.